Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer immunity and immunotherapy beyond COVID-19.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Bellone M, et al. Among authors: brevi a. Cancer Immunol Immunother. 2023 Jul;72(7):2541-2548. doi: 10.1007/s00262-023-03411-9. Epub 2023 Mar 30. Cancer Immunol Immunother. 2023. PMID: 36995489 Free PMC article. No abstract available.
Live Biotherapeutic Products as Cancer Treatments.
Brevi A, Zarrinpar A. Brevi A, et al. Cancer Res. 2023 Jun 15;83(12):1929-1932. doi: 10.1158/0008-5472.CAN-22-2626. Cancer Res. 2023. PMID: 37317784 Free PMC article.
Engineered bacterial therapeutics for detecting and treating CRC.
Siguenza N, Brevi A, Zhang JT, Pabani A, Bhushan A, Das M, Ding Y, Hasty J, Ghosh P, Zarrinpar A. Siguenza N, et al. Among authors: brevi a. Trends Cancer. 2024 Jul;10(7):588-597. doi: 10.1016/j.trecan.2024.04.001. Epub 2024 Apr 30. Trends Cancer. 2024. PMID: 38693003 Free PMC article. Review.
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Bellone M, et al. Among authors: brevi a. Cancer Immunol Immunother. 2022 Jul;71(7):1787-1794. doi: 10.1007/s00262-022-03145-0. Epub 2022 Jan 16. Cancer Immunol Immunother. 2022. PMID: 35034143 Free PMC article. No abstract available.
[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma.
Valtorta S, Toscani D, Chiu M, Sartori A, Coliva A, Brevi A, Taurino G, Grioni M, Ruffini L, Vacondio F, Zanardi F, Bellone M, Moresco RM, Bussolati O, Giuliani N. Valtorta S, et al. Among authors: brevi a. Front Oncol. 2021 Oct 12;11:760732. doi: 10.3389/fonc.2021.760732. eCollection 2021. Front Oncol. 2021. PMID: 34712616 Free PMC article.
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S, Grioni M, Brambillasca CS, Monno A, Brevi A, Freschi M, Piras IS, Elia AR, Pieri V, Baccega T, Lombardo A, Galli R, Briganti A, Doglioni C, Jachetti E, Bellone M. Caputo S, et al. Among authors: brevi a. Front Immunol. 2020 Sep 10;11:1820. doi: 10.3389/fimmu.2020.01820. eCollection 2020. Front Immunol. 2020. PMID: 33013832 Free PMC article.
A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic.
Zaniboni A, Ghidini M, Grossi F, Indini A, Trevisan F, Iaculli A, Dottorini L, Moleri G, Russo A, Vavassori I, Brevi A, Rausa E, Boni L, Dondossola D, Valeri N, Ghidini A, Tomasello G, Petrelli F. Zaniboni A, et al. Among authors: brevi a. Cancers (Basel). 2020 Aug 29;12(9):2452. doi: 10.3390/cancers12092452. Cancers (Basel). 2020. PMID: 32872421 Free PMC article. Review.
29 results